SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MAXR, TIG, AJRD, QUMU

Allarity Therapeutics Inc

Change company Symbol lookup

Select an option...

ALLR Allarity Therapeutics Inc

SIVB SVB Financial Group

LYLT Loyalty Ventures Inc

NMRD Nemaura Medical Inc

LOGI Logitech International SA

BIOC Biocept Inc

KT KT Corp

SVRA Savara Inc

KA Kineta Inc

IMNM Immunome Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |

Company profile

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company. The Company is engaged in targeting some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates together with its Drug Response Predictor (DRP) companion diagnostics in a precision medicine approach. The Company's products include dovitinib, stenoparib, and IXEMPRA (ixabepilone). The lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including FGFR and VEGFR. The therapeutic candidate is stenoparib is a novel inhibitor of the key deoxyribonucleic acid (DNA) damage repair enzyme poly-ADP-ribose polymerase (PARP). The therapeutic candidate is IXEMPRA (ixabepilone) is a selective microtubule inhibitor. The DRP technology is a diagnostic platform that models human tumor biology and can help predict whether a cancer patient respond or not to a particular drug.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MAXR, TIG, AJRD, QUMU

11:20 am ET January 3, 2023 (PR Newswire) Print

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

https://mma.prnewswire.com/media/1896150/Firm_Logo_with_Investor_Law_Firm_Logo.jpg

Maxar Technologies Inc. (NYSE: MAXR)'ssale to Advent International for $53.00 per share in cash. If you are a Maxar shareholder, click here to learn more about your legal rights and options.

Trean Insurance Group, Inc. (NASDAQ: TIG)'ssale to affiliates of Altaris, LLC for $6.15 in cash per share. If you are a Trean shareholder, click here to learn more about your rights and options.

Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD)'ssale to L3Harris Technologies for $58.00 per share. If you are an Aerojet shareholder, click here to learn more about your rights and options.

Qumu Corporation (NASDAQ: QUMU)'ssale toEnghouse Systems Ltd. for $0.90 per share in cash.If you are a Qumu shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.comor zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com https://www.halpersadeh.com

https://c212.net/c/img/favicon.png?sn=NY76589&sd=2023-01-03

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-maxr-tig-ajrd-qumu-301712355.html

SOURCE Halper Sadeh LLP

https://rt.newswire.ca/rt.gif?NewsItemId=NY76589&Transmission_Id=202301031120PR_NEWS_USPR_____NY76589&DateId=20230103

COMTEX_421828085/1005/2023-01-03T11:20:09